메뉴 건너뛰기
Cancer Epidemiology Biomarkers and Prevention
Volumn 16, Issue 4, 2007, Pages 740-746
Age at menarche and menopause and breast cancer risk in the International BRCA1/2 Carrier Cohort Study

(115)  Chang Claude, Jenny a   Andrieu, Nadine b,q   Rookus, Matti c   Brohet, Richard c   Antoniou, Antonis C d   Peock, Susan d,z   Davidson, Rosemarie e,ai   Izatt, Louise f,aj   Cole, Trevor g   Noguès, Catherine h,ar,au   Luporsi, Elisabeth i,ay   Huiart, Laetitia j,az   Hoogerbrugge, Nicoline k   Van Leeuwen, Flora E c   Osorio, Ana l   Eyfjord, Jorunn m   Radice, Paolo n,o   Goldgar, David E p   Easton, Douglas F d   Wagner, Teresa r   more..

b INSERM   (France)
Author keywords

[No Author keywords available]
Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;
EID: 34247504165     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0829     Document Type: Article
Times cited : (67)
References (21)
  • 1
    • 0038744296 scopus 로고    scopus 로고
    • Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies
    • Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003;72:1117-30.
    • (2003) Am J Hum Genet , vol.72 , pp. 1117-1130
    • Antoniou, A.1    Pharoah, P.D.2    Narod, S.3
  • 2
    • 0027257237 scopus 로고
    • Breast cancer: Magnitude of the problem and descriptive epidemiology
    • Kelsey JL, Horn-Ross PL. Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol Rev 1993;15:7-16.
    • (1993) Epidemiol Rev , vol.15 , pp. 7-16
    • Kelsey, J.L.1    Horn-Ross, P.L.2
  • 3
    • 0019447387 scopus 로고
    • Morphological evaluation of cell turnover in relation to the menstrual cycle in the "resting" human breast
    • Ferguson DJ, Anderson TJ. Morphological evaluation of cell turnover in relation to the menstrual cycle in the "resting" human breast. Br J Cancer 1981;44:177-81.
    • (1981) Br J Cancer , vol.44 , pp. 177-181
    • Ferguson, D.J.1    Anderson, T.J.2
  • 4
    • 0027304028 scopus 로고
    • Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk
    • Pike M-C, Spicer D-V, Dahmoush L, Press M-F. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993;15:17-35.
    • (1993) Epidemiol Rev , vol.15 , pp. 17-35
    • Pike, M.-C.1    Spicer, D.-V.2    Dahmoush, L.3    Press, M.-F.4
  • 5
    • 0030843969 scopus 로고    scopus 로고
    • Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
    • Collaborative Group on Hormonal Factors in Breast Cancer
    • Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350:1047-59.
    • (1997) Lancet , vol.350 , pp. 1047-1059
  • 6
    • 0034075592 scopus 로고    scopus 로고
    • Variation in the interaction between familial and reproductive factors on the risk of breast cancer according to age, menopausal status, and degree of familiarity
    • Andrieu N, Prevost T, Rohan TE, et al. Variation in the interaction between familial and reproductive factors on the risk of breast cancer according to age, menopausal status, and degree of familiarity. Int J Epidemiol 2000;29:214-23.
    • (2000) Int J Epidemiol , vol.29 , pp. 214-223
    • Andrieu, N.1    Prevost, T.2    Rohan, T.E.3
  • 7
    • 0035960431 scopus 로고    scopus 로고
    • Famililal breast cancer: Collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease
    • Collaborative Group on Hormonal Factors in Breast Cancer
    • Collaborative Group on Hormonal Factors in Breast Cancer. Famililal breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 2001;358:1389-99.
    • (2001) Lancet , vol.358 , pp. 1389-1399
  • 8
    • 22344443194 scopus 로고    scopus 로고
    • Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype
    • Lakhani SR, Reis-Filho JS, Fulford L, et al. Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res 2005;11:5175-80.
    • (2005) Clin Cancer Res , vol.11 , pp. 5175-5180
    • Lakhani, S.R.1    Reis-Filho, J.S.2    Fulford, L.3
  • 9
    • 0033199926 scopus 로고    scopus 로고
    • Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers [see comments]
    • Rebbeck TR, Levin AM, Eisen A, et al. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers [see comments]. J Natl Cancer Inst 1999;91:1475-9.
    • (1999) J Natl Cancer Inst , vol.91 , pp. 1475-1479
    • Rebbeck, T.R.1    Levin, A.M.2    Eisen, A.3
  • 10
    • 0037162110 scopus 로고    scopus 로고
    • Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations
    • Rebbeck TR, Lynch HT, Neuhausen SL, et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 2002;346:1616-22.
    • (2002) N Engl J Med , vol.346 , pp. 1616-1622
    • Rebbeck, T.R.1    Lynch, H.T.2    Neuhausen, S.L.3
  • 11
    • 0037162115 scopus 로고    scopus 로고
    • Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation
    • Kauff ND, Satagopan JM, Robson ME, et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2002;346:1609-15.
    • (2002) N Engl J Med , vol.346 , pp. 1609-1615
    • Kauff, N.D.1    Satagopan, J.M.2    Robson, M.E.3
  • 12
    • 2942739225 scopus 로고    scopus 로고
    • Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
    • Metcalfe K, Lynch HT, Ghadirian P, et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 2004;22:2328-35.
    • (2004) J Clin Oncol , vol.22 , pp. 2328-2335
    • Metcalfe, K.1    Lynch, H.T.2    Ghadirian, P.3
  • 13
    • 29144522408 scopus 로고    scopus 로고
    • Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: An international case-control study
    • Eisen A, Lubinski J, Klijn J, et al. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study. J Clin Oncol 2005;23:7491-6.
    • (2005) J Clin Oncol , vol.23 , pp. 7491-7496
    • Eisen, A.1    Lubinski, J.2    Klijn, J.3
  • 14
    • 33344469058 scopus 로고    scopus 로고
    • Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: A prospective cohort study
    • Domchek SM, Friebel TM, Neuhausen SL, et al. Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Lancet Oncol 2006;7:223-9.
    • (2006) Lancet Oncol , vol.7 , pp. 223-229
    • Domchek, S.M.1    Friebel, T.M.2    Neuhausen, S.L.3
  • 15
    • 23444448778 scopus 로고    scopus 로고
    • Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    • Kotsopoulos J, Lubinski J, Lynch HT, et al. Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Cancer Causes Control 2005,16:667-74.
    • (2005) Cancer Causes Control , vol.16 , pp. 667-674
    • Kotsopoulos, J.1    Lubinski, J.2    Lynch, H.T.3
  • 16
    • 85009968304 scopus 로고    scopus 로고
    • The International BRCA1/2 Carrier Cohort Study: Purpose, rationale, and study design
    • The IBCCS Collaborators Group
    • The IBCCS Collaborators Group. The International BRCA1/2 Carrier Cohort Study: purpose, rationale, and study design. Breast Cancer Res 2002;2:E010.
    • (2002) Breast Cancer Res , vol.2
  • 17
    • 21344437509 scopus 로고    scopus 로고
    • A weighted cohort approach for analysing factors modifying disease risks in carriers of high-risk susceptibility genes
    • Antoniou AC, Goldgar DE, Andrieu N, et al. A weighted cohort approach for analysing factors modifying disease risks in carriers of high-risk susceptibility genes. Genet Epidemiol 2005;29:1-11.
    • (2005) Genet Epidemiol , vol.29 , pp. 1-11
    • Antoniou, A.C.1    Goldgar, D.E.2    Andrieu, N.3
  • 18
    • 84892372742 scopus 로고
    • The robust inference for the Cox proportional Hazards model
    • Lin DY, Wei LJ. The robust inference for the Cox proportional Hazards model. JASA 1989;84:1074-8.
    • (1989) JASA , vol.84 , pp. 1074-1078
    • Lin, D.Y.1    Wei, L.J.2
  • 19
    • 0025258839 scopus 로고
    • Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: Associations and interactions in an international case-control study
    • Hsieh CC, Trichopoulos D, Katsouyanni K, Yuasa S. Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: associations and interactions in an international case-control study. Int J Cancer 1990;46:796-800.
    • (1990) Int J Cancer , vol.46 , pp. 796-800
    • Hsieh, C.C.1    Trichopoulos, D.2    Katsouyanni, K.3    Yuasa, S.4
  • 20
    • 0038298773 scopus 로고    scopus 로고
    • Breast cancers among very young premenopausal women (United States)
    • Althuis MD, Brogan DD, Coates RJ, et al. Breast cancers among very young premenopausal women (United States). Cancer Causes Control 2003;14:151-60.
    • (2003) Cancer Causes Control , vol.14 , pp. 151-160
    • Althuis, M.D.1    Brogan, D.D.2    Coates, R.J.3
  • 21
    • 33644843874 scopus 로고    scopus 로고
    • Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers
    • Kramer JL, Velazquez IA, Chen BE, Rosenberg PS, Struewing JP, Greene MH. Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers. J Clin Oncol 2005;23:8629-35.
    • (2005) J Clin Oncol , vol.23 , pp. 8629-8635
    • Kramer, J.L.1    Velazquez, I.A.2    Chen, B.E.3    Rosenberg, P.S.4    Struewing, J.P.5    Greene, M.H.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.